Evaluating virus-transformed cell tumorigenicity

Journal of Virological Methods

Volumn 79, Issue 1, 1999, Pages 41-50

  Lewis Jr, Andrew M ^a   Alling, David W ^b   Banks, Steven M ^b   Soddu, Silvia ^a   Cook, James L ^c  

^a Viral Pathogenesis Section   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Adenovirus type 12; Animal models; DNA tumor viruses; Simian virus 40; Transformed phenotype; Tumorigenicity; Tumorigenicity assays

Indexed keywords

ADENOVIRUS 12; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; DNA TUMOR VIRUS; HAMSTER; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIMIAN VIRUS 40;

ADENOVIRIDAE; ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELL TRANSPLANTATION; CRICETINAE; EVALUATION STUDIES; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; PHENOTYPE; SIMIAN VIRUS 40;

EID: 0345435044     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00182-7     Document Type: Article

References (17)

1. Cornell R.G. Karber method. Katz S., Johnson N.L. Encyclopedia of Statistical Sciences. 1981;354-357 Wiley, New York.
2. Drakin M.S., Appella E., Law L.W. Immunogenic properties of a soluble tumor-specific transplantation antigen induced by simian virus 40. J. Natl. Cancer Inst. 52:1974;259-264.
3. Eyler Y.L., Siwarski D.F., Huppi K.E., Lewis A.M. Jr A p-53 mutation in exon 5 associated with adenovirus transformation. Mol. Carcinog. 12:1995;1-6.
4. Gershwin M.E., Ikeda R.M., Kawakami T.G., Owens R.B. Immunobiology of heterotransplanted human tumors in nude mice. J. Natl. Cancer Inst. 58:1977;1455-1461.
5. Haddada H., Sogn J.A., Coligan J.E., Carbone M., Dixon K., Levine A.S., Lewis A.M. Jr Viral gene inhibition of class I major histocompatibility antigen expression: not a general mechanism governing the tumorigenicity of adenovirus type 2-, adenovirus type 12-, and simian virus 40-transformed Syrian hamster cells. J. Virol. 62:1988;2755-2761.
6. Halachimi E., Witz I.P. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity. Cancer Res. 49:1989;2383-2389.
7. Hill R.P., Chambers A.F., Ling V., Harris J.F. Dynamic heterogeneity: Rapid generation of metastatic variants in B16 melanoma cells. Science. 224:1984;998-1000.
8. Kuroki T., Huh N.H. Why are human cells resistant to malignant cell transformation in vitro? Jpn. J. Cancer Res. 84:1993;1091-1100.
9. Lewis A.M. Jr, Cook J.L. Spectrum of tumorigenic phenotyes among adenovirus 2-, adenovirus 12-, and simian virus 40-transformed Syrian hamster cells defined by host cellular immune-tumor cell interactions. Cancer Res. 42:1982;939-944.
10. Lewis A.M. Jr, Banks S.M., Soddu S., Cook J.L. The effects of endpoint overdispersion on the validity of single-dose tumorigenicity assays. Cancer Lett. 93:1995;179-186.
11. Little J., Alling D.W., Asofsky R. Induction of differentiation in a B lymphoma X B lymphocyte hybrid line II. Intraclonal heterogeneity in growth, secretion of IgM and cytokine production in response to lipopolysaccharide. J. Immunol. 150:1993;2129-2138.
12. Miller R.G. Nonparametric estimators of the mean tolerance in bioassay. Biometrica. 60:1973;535-542.
13. Namba M., Iijima M., Tondo T., Jahan I., Mihara K. Immortalization of normal human cells is a multistep process and a rate limiting step of neoplastic transformation of the cells. Hum. Cell. 6:1993;253-259.
14. Paweletz N., Knerim H. Tumor-related angiogenesis. Crit. Rev. Oncol. Hematol. 9:1989;197-242.
15. Prager D., Li H.L., Asa S., Malmed S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor-1 receptor mutant. Proc. Natl. Acad. Sci. USA. 91:1994;2181-2185.
16. Tevethia S.S., Butel J.S. Induction of common transplantation antigen by various isolates of papovirus SV40 and by virus rescued from transformed cells. Intervirology. 2:1973;200-205.
17. WHO, 1998. WHO Technical Report Series No. 878, Annex 1. WHO, Geneva, pp. 20-53.